PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
22-Dec-2025 Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease Businesswire
22-Dec-2025 Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma Businesswire
22-Dec-2025 Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer Businesswire
22-Dec-2025 Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025 Businesswire
22-Dec-2025 FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma Businesswire
22-Dec-2025 1933 Industries Achieves Positive Income in Q1 2026, Marking Third Consecutive Profitable Quarter ACCESS Newswire
22-Dec-2025 Black Book Poll: "Governed AI" Emerges as the Deciding Factor in 2026 NHS Procurement ACCESS Newswire
22-Dec-2025 Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares ACCESS Newswire
22-Dec-2025 Faron Announces Strategic Collaboration with The Institute for Cancer Research to Launch BLAZE Trial, Targeting Immunotherapy Resistance in Cancer ACCESS Newswire
22-Dec-2025 Nomination Committee Appointed for AGM 2026 in Ascelia Pharma AB ACCESS Newswire
20-Dec-2025 After Trump's Marijuana Executive Order, Will the DEA Face a Court Imposed Deadline from MMJ's Writ of Mandamus? ACCESS Newswire
20-Dec-2025 Black Book Research Releases Its 2026 Annual Methodology and Governance Statement for Healthcare IT Vendor Rankings ACCESS Newswire
20-Dec-2025 Awake Breast Augmentation: Gruber Plastic Surgery Highlights Live Implant Sizing Under Local Anesthesia With No Sedation for Eligible Patients ACCESS Newswire
19-Dec-2025 ENT Disorder Treatment: Global Market Trends, Regional Outlook and Growth Forecast 2025-2032 - Surge in Reimbursement Approvals for Novel Biologics Treating Severe Allergic & Chronic Sinusitis - ResearchAndMarkets.com Businesswire
19-Dec-2025 Thyroid Eye Disease (TED) Treatments Market Nears $4.3 Billion by 2032: Emerging Small Molecule Therapies Targeting Orbital Fibroblasts Drive Revenue Growth - ResearchAndMarkets.com Businesswire
19-Dec-2025 Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans Businesswire
19-Dec-2025 Trends and Strategies Shaping the $4 Billion Narcolepsy Treatment Market, 2025-2032: Drug Classes, Disorder Types, Age Groups, Distribution Channels, Regions, Key Companies - ResearchAndMarkets.com Businesswire
19-Dec-2025 Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans Businesswire
19-Dec-2025 Central Nervous System (CNS) Therapeutics Strategic Business Report 2025-2030 - Biologics, Gene Therapies, and Small Molecules Converge in Development Pipelines for CNS Disorders - ResearchAndMarkets.com Businesswire
19-Dec-2025 Genentech Announces Agreement With U.S. Government Businesswire